Appendix 2—table 25. Statin Cohort (Region=New York State), Patient Characteristics Pre/Post Match.
| Region=NY by Statin Use: Unmatched | Region=NY by Statin Use: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Statin Non-users | Statin Users | p-value | All | Statin Non-users | Statin Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 968,296 | 100.0% | 761,995 | 78.7% | 206,301 | 21.3% | 371,072 | 100.0% | 185,536 | 50.0% | 185,536 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 133,178 | 13.8% | 133,111 | 17.5% | 67 | 0.0% | <0.001 | 134 | 0.0% | 67 | 0.0% | 67 | 0.0% | 1.00 |
| 21-40 | 192,959 | 19.9% | 188,446 | 24.7% | 4,513 | 2.2% | 9,019 | 2.4% | 4,508 | 2.4% | 4,511 | 2.4% | ||
| 41-50 | 127,794 | 13.2% | 112,342 | 14.7% | 15,452 | 7.5% | 30,860 | 8.3% | 15,420 | 8.3% | 15,440 | 8.3% | ||
| 51-60 | 172,444 | 17.8% | 128,472 | 16.9% | 43,972 | 21.3% | 86,136 | 23.2% | 43,068 | 23.2% | 43,068 | 23.2% | ||
| 61-70 | 159,912 | 16.5% | 100,884 | 13.2% | 59,028 | 28.6% | 106,460 | 28.7% | 53,233 | 28.7% | 53,227 | 28.7% | ||
| 71-80 | 120,117 | 12.4% | 64,549 | 8.5% | 55,568 | 26.9% | 91,337 | 24.6% | 45,675 | 24.6% | 45,662 | 24.6% | ||
| ≥81 | 61,892 | 6.4% | 34,191 | 4.5% | 27,701 | 13.4% | 47,126 | 12.7% | 23,565 | 12.7% | 23,561 | 12.7% | ||
| Gender | ||||||||||||||
| Female | 573,610 | 59.2% | 454,050 | 59.6% | 119,560 | 58.0% | <0.001 | 215,375 | 58.0% | 107,420 | 57.9% | 107,955 | 58.2% | 0.08 |
| Male | 394,686 | 40.8% | 307,945 | 40.4% | 86,741 | 42.0% | 155,697 | 42.0% | 78,116 | 42.1% | 77,581 | 41.8% | ||
| Insurance | ||||||||||||||
| Commercial | 500,918 | 51.7% | 442,990 | 58.1% | 57,928 | 28.1% | <0.001 | 116,123 | 31.3% | 58,206 | 31.4% | 57,917 | 31.2% | 0.57 |
| Dual | 6,814 | 0.7% | 2,410 | 0.3% | 4,404 | 2.1% | 4,447 | 1.2% | 2,190 | 1.2% | 2,257 | 1.2% | ||
| Medicaid | 252,366 | 26.1% | 206,109 | 27.0% | 46,257 | 22.4% | 83,550 | 22.5% | 41,703 | 22.5% | 41,847 | 22.6% | ||
| Medicare | 208,198 | 21.5% | 110,486 | 14.5% | 97,712 | 47.4% | 166,952 | 45.0% | 83,437 | 45.0% | 83,515 | 45.0% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 521,282 | 53.8% | 446,929 | 58.7% | 74,353 | 36.0% | <0.001 | 146,967 | 39.6% | 73,675 | 39.7% | 73,292 | 39.5% | 0.20 |
| Yes | 447,014 | 46.2% | 315,066 | 41.3% | 131,948 | 64.0% | 224,105 | 60.4% | 111,861 | 60.3% | 112,244 | 60.5% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.65 | 1.39 | 0.51 | 1.24 | 1.17 | 1.77 | <0.001 | 1.07 | 1.73 | 1.08 | 1.76 | 1.06 | 1.70 | <0.001 |
CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.